SCHEMBL3758000

SCHEMBL3758000

COc1cccc(S(=O)(=O)Nc2ccccc2)c1

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PGR P06401 6/20 0.83
GAA P10253 1/20 0.70
KEAP1 Q14145 2/20 0.68
NFE2L2 Q16236 2/20 0.68
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
FFAR4 Q5NUL3 1/20 0.64
POLB P06746 1/20 0.64
RORA P35398 1/20 0.64
RORC P51449 1/20 0.64
NR1H2 P55055 1/20 0.64
ALPL P05186 1/20 0.64
CA12 O43570 1/20 0.63
CA9 Q16790 1/20 0.63
CYP11B1 P15538 1/20 0.62
CYP11B2 P19099 1/20 0.62
CYP19A1 P11511 1/20 0.62
PLAU P00749 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4662755 0.90 PGR (0.72) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL9234846 0.87 PGR (0.73) PGRKEAP1ALDH1A1POLB
SCHEMBL7181531 0.86 PGR (0.72) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL2959233 0.86 PGR (0.72) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL1629146 0.86 PGR (0.74) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL5329582 0.86 PGR (0.71) PGRGAAALDH1A1LMNARORA
SCHEMBL20323615 0.85 HTR6 (0.66) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL7183197 0.85 GAA (0.64) PGRGAAKEAP1NFE2L2ALDH1A1
SCHEMBL8081768 0.82 KEAP1 (0.79) PGRGAAKEAP1ALDH1A1POLB
SCHEMBL31681417 0.82 CYP19A1 (0.68) PGRALDH1A1LMNAPOLBCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858796-B2 Chemical compounds GLAXO GROUP LIMITED (GB) 2010-12-28 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
WO-2008142376-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS INHIBOX LTD. (GB) 2008-11-27 WO disclosed
US-20070254873-A1 Chemical Compounds GLAXO GROUP LIMITED (GB) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents TNF, CS, COASY PGR 2436/4885GAA 199/4885KEAP1 1160/4885
US-20070254873-A1 Chemical Compounds IKBKG, NFKBIA, RELA PGR 3567/4885GAA 4581/4885KEAP1 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.